Flotek Industries vs Orion
FTK and OEC side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FTK and OEC compare
Flotek Industries is the larger company, worth 4.2 times as much as Orion ($936M against $224M).
Flotek Industries grew revenue faster over the last twelve months (59.3% versus 0.86% for Orion).
Flotek Industries keeps more of each dollar of sales as profit, with a net margin of 8.8% compared with −1.8% at Orion.
Orion pays a dividend yielding 1.6%; Flotek Industries does not pay one.
Flotek Industries scores higher on the StockData Score (11 against 8 for Orion), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FTK | OEC |
|---|---|---|
| Size and price | ||
| Market cap | $936M | $224M |
| Share price | $25.83 | $3.97 |
| Change, 1 year | 67.5% | −20.3% |
| Change, 5 years | 419% | −78.3% |
| Beta (5Y) | 1.19 | 1.06 |
| Employees | 158 | 1,650 |
| StockData Score | ||
| Total score | 11 (better) | 8 |
| Valuation score | 1 | 4 (better) |
| Growth score | 3 (better) | 0 |
| Performance score | 4 (better) | 0 |
| Health score | 3 (better) | 2 |
| Dividend score | 0 | 2 (better) |
| Valuation | ||
| P/E | 32.3× | – |
| P/S | 2.7× | 0.1× (better) |
| P/B | 6.5× | 0.6× (better) |
| EV/EBITDA | 19.7× | 5.3× (better) |
| P/FCF | – | 5.1× |
| FCF yield | – | 19.4% |
| Fair value | $21.70 | $25.79 |
| Margin of safety | −19.0% | 84.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 59.3% (better) | 0.86% |
| Revenue growth, 5Y average | 34.9% (better) | 9.7% |
| Net income growth (TTM) | −3.1% | – |
| EPS growth (TTM) | −10.1% | – |
| Profitability | ||
| Gross margin | 23.3% (better) | 18.5% |
| Operating margin | 13.2% (better) | 4.0% |
| Net margin | 8.8% (better) | −1.8% |
| FCF margin | – | 2.4% |
| Return on equity | 24.4% (better) | −8.1% |
| Return on invested capital | 30.8% (better) | 2.7% |
| Financial health | ||
| Debt / equity | – | 2.48 |
| Net debt / EBITDA | – | 4.30 |
| Interest coverage | 8.5× | – |
| Current ratio | 2.30 (better) | 1.06 |
| Altman Z-score | 4.28 (better) | 1.44 |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | – | 1.6% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | −16.7% |
| Buyback yield | −0.02% | 0.36% (better) |
| Shareholder yield | −0.02% | 1.9% (better) |
| Ownership | ||
| Held by institutions | 34.7% | 94.1% |
| Held by insiders | 65.1% | 4.1% |
| Insider net buying, 12 months | −$26.0M | – |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 33.9% | 4.0% |
Go deeper
- FTK stock overview
- FTK income statement
- FTK valuation and score
- OEC stock overview
- OEC income statement
- OEC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.